SG11201900210PA - Composition for controlling acquired immune function suppression due to anti-influenza drug, and production method for same - Google Patents
Composition for controlling acquired immune function suppression due to anti-influenza drug, and production method for sameInfo
- Publication number
- SG11201900210PA SG11201900210PA SG11201900210PA SG11201900210PA SG11201900210PA SG 11201900210P A SG11201900210P A SG 11201900210PA SG 11201900210P A SG11201900210P A SG 11201900210PA SG 11201900210P A SG11201900210P A SG 11201900210PA SG 11201900210P A SG11201900210P A SG 11201900210PA
- Authority
- SG
- Singapore
- Prior art keywords
- composition
- production method
- same
- immune function
- acquired immune
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 230000036737 immune function Effects 0.000 title 1
- 206010022000 influenza Diseases 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000001629 suppression Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/123—Bulgaricus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/137—Delbrueckii
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016159824A JP6777911B2 (en) | 2016-08-17 | 2016-08-17 | Fermented milk for suppressing the decrease in immune function acquired by anti-influenza drugs and its manufacturing method |
PCT/JP2017/029355 WO2018034279A1 (en) | 2016-08-17 | 2017-08-15 | Composition for controlling acquired immune function suppression due to anti-influenza drug, and production method for same |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201900210PA true SG11201900210PA (en) | 2019-02-27 |
Family
ID=61196651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201900210PA SG11201900210PA (en) | 2016-08-17 | 2017-08-15 | Composition for controlling acquired immune function suppression due to anti-influenza drug, and production method for same |
Country Status (5)
Country | Link |
---|---|
US (1) | US20190150463A1 (en) |
JP (1) | JP6777911B2 (en) |
CN (1) | CN109475585A (en) |
SG (1) | SG11201900210PA (en) |
WO (1) | WO2018034279A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100278795A1 (en) * | 2007-11-19 | 2010-11-04 | Kaneka Corporation | Lactic acid bacterium-containing preparation |
EP3040083B1 (en) * | 2013-08-26 | 2018-11-21 | Meiji Co., Ltd. | Antibody titer-increasing agent using lactic acid bacterium |
-
2016
- 2016-08-17 JP JP2016159824A patent/JP6777911B2/en active Active
-
2017
- 2017-08-15 CN CN201780042693.2A patent/CN109475585A/en active Pending
- 2017-08-15 WO PCT/JP2017/029355 patent/WO2018034279A1/en active Application Filing
- 2017-08-15 US US16/317,684 patent/US20190150463A1/en not_active Abandoned
- 2017-08-15 SG SG11201900210PA patent/SG11201900210PA/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN109475585A (en) | 2019-03-15 |
WO2018034279A1 (en) | 2018-02-22 |
JP2018027904A (en) | 2018-02-22 |
JP6777911B2 (en) | 2020-10-28 |
US20190150463A1 (en) | 2019-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL250744A0 (en) | Method of producing palbociclib and pharmaceutical compositions comprising the same | |
EP3397260A4 (en) | Methods and compositions relating to chondrisomes from blood products | |
ZA201608077B (en) | Combination, composition, and method of administering the combination or composition to animals | |
PL3442480T3 (en) | Topical administration method | |
EP3302783A4 (en) | Production of metal-organic frameworks | |
GB201612853D0 (en) | Solid dosage form production | |
HK1231416A1 (en) | Complexes of sirolimus and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
HK1232229A1 (en) | Novel compound of 4-thionucleoside, as well as preparation method therefor, pharmaceutical composition thereof and application thereof 4- | |
EP3156037A4 (en) | Alpha-gel-intermediate composition, and production method for alpha-gel-containing o/w emulsion cosmetic using said composition | |
PL3309138T3 (en) | Method for co-production of 2,3,3,3-tetrafluoropropylene and 1,3,3,3-tetrafluoropropylene | |
EP3156043A4 (en) | A-gel-intermediate composition, and production method for a-gel-containing o/w emulsion cosmetic using said composition | |
HK1256362A1 (en) | Cocrystal, production method thereof, and medicament containing cocrystal | |
PT3202759T (en) | Alpha-aminoamide derivative compound and pharmaceutical composition comprising same | |
SI3672770T1 (en) | Method for the production of curved furniture components | |
EP3206771C0 (en) | Method for adjusting the composition of chromatography products | |
EP3538126A4 (en) | Bacteriocin production, compositions and methods of use | |
EP3170794A4 (en) | Composition including silicotitanate having sitinakite structure, and production method for same | |
IL249010A0 (en) | Pharmaceutical composition comprising pyrazine carboxamide compound as active ingredient | |
EP3347380A4 (en) | Enhanced delivery of drugs to the brain | |
HK1223837A1 (en) | Compositions and methods for reducing overdose | |
HK1214767A1 (en) | Tablet-formed pharmaceutical composition and preparation method thereof | |
EP3378493A4 (en) | Novel anti-cancer drug nano-preparation and preparation method therefor | |
EP3151826A4 (en) | Omega-3 compositions, dosage forms, and methods of use | |
EP3398949A4 (en) | Uses of compound in preparation of drugs for treating brain glioma | |
SG11201900210PA (en) | Composition for controlling acquired immune function suppression due to anti-influenza drug, and production method for same |